Understanding how a specific receptor affects immune response in Pneumocystis pneumonia.
The Role of the EphA2 Receptor Kinase Pathway in Pneumocystis Pneumonia (PCP)
This study is looking at how a specific protein in immune cells affects the body's response to a serious lung infection called Pneumocystis pneumonia, which often affects people with AIDS, to find new ways to help improve their immune system and reduce lung damage.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10988290 on NIH RePORTER |
What this research studies
This research investigates the role of the EphA2 receptor kinase pathway in the immune response of alveolar macrophages during Pneumocystis pneumonia (PCP), a serious infection often seen in individuals with AIDS. The study aims to uncover how this receptor influences the attachment of the Pneumocystis fungus to immune cells and its subsequent effects on inflammation and lung injury. By examining the interactions between the EphA2 receptor and Pneumocystis, researchers hope to identify new therapeutic targets that could enhance the immune response in affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with AIDS or other immunosuppressive conditions who are at risk for Pneumocystis pneumonia.
Not a fit: Patients who do not have compromised immune systems or who are not at risk for Pneumocystis pneumonia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for Pneumocystis pneumonia, potentially reducing morbidity and mortality in patients with compromised immune systems.
How similar studies have performed: Previous research has shown the importance of the EphA2 receptor in immune responses, suggesting that this approach may yield valuable insights and potential breakthroughs.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Limper, Andrew H — Mayo Clinic Rochester
- Study coordinator: Limper, Andrew H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.